These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmachem's salazopyrine in rheumatoid arthritis]. Konstantinova M; Konstantinova V Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958 [TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis. Hoza J; Kadlecová T; Nĕmcová D; Havelka S Acta Univ Carol Med (Praha); 1991; 37(1-2):80-3. PubMed ID: 1688268 [TBL] [Abstract][Full Text] [Related]
4. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Szyper-Kravitz M Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953 [No Abstract] [Full Text] [Related]
5. [Salazopyrine in the treatment of rheumatoid arthritis]. Villar Grimalt A; Puche Azorín P Med Clin (Barc); 1987 Mar; 88(12):519-20. PubMed ID: 2884366 [No Abstract] [Full Text] [Related]
6. Sulfasalazine treatment in juvenile chronic arthritis: an open study. Joos R; Veys EM; Mielants H; van Werveke S; Goemaere S J Rheumatol; 1991 Jun; 18(6):880-4. PubMed ID: 1680193 [TBL] [Abstract][Full Text] [Related]
7. [Experience in the use of salazopyrine EN in patients with spondylarthritis ankylopoietica and rheumatoid arthritis]. Somhegyi A; Gömör B Orv Hetil; 1988 Sep; 129(36):1917-21. PubMed ID: 2902550 [No Abstract] [Full Text] [Related]
8. DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy. Piñana E; Lei SH; Merino R; Melgosa M; De La Vega R; Gonzales-Obeso E; Ramírez E; Borobia A; Carcas A J Clin Pharm Ther; 2010 Jun; 35(3):365-70. PubMed ID: 20831538 [TBL] [Abstract][Full Text] [Related]
9. [Salazopyrine and reactive arthritis]. Valverde García J; Nolla Solé JM; Juanola Roura X Med Clin (Barc); 1987 Oct; 89(10):442. PubMed ID: 2890799 [No Abstract] [Full Text] [Related]
10. Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report. Topaloğlu R; Kiper N; Göçmen A; Varan B; Saatçi U Turk J Pediatr; 2000; 42(2):148-50. PubMed ID: 10936982 [TBL] [Abstract][Full Text] [Related]
11. Recognition and management of macrophage activation syndrome in juvenile arthritis. Kelly A; Ramanan AV Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614 [TBL] [Abstract][Full Text] [Related]
12. [The treatment of inflammatory diseases of the colon with salazopyrine]. Chevrel B Med Chir Dig; 1982; 11(3):227-30. PubMed ID: 6124663 [No Abstract] [Full Text] [Related]
18. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Tristano AG Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366 [TBL] [Abstract][Full Text] [Related]
19. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Lard LR; Visser H; Speyer I; vander Horst-Bruinsma IE; Zwinderman AH; Breedveld FC; Hazes JM Am J Med; 2001 Oct; 111(6):446-51. PubMed ID: 11690569 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of coagulation abnormalities in juvenile rheumatoid arthritis. Mukamel M; Bernstein BH; Brik R; Lehman TJ J Rheumatol; 1987 Dec; 14(6):1147-9. PubMed ID: 3437422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]